New Pulsed Field Ablation for Atrial Fibrillation
Part of Heart & circulation clinical trials.
This trial tests a newer ablation procedure (PulseSelect) to treat atrial fibrillation—a common heart rhythm problem. The goal is to see if this optimized workflow helps patients have fewer symptoms and better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–80 years old
- You have symptomatic atrial fibrillation that comes back often (paroxysmal) or lasts continuously for days to weeks (persistent)
- Your atrial fibrillation is documented with ECG recordings within the last 12 months
- You are willing to take blood thinners (anticoagulation) for at least 3 weeks before the procedure and during follow-up
- You do not have a pacemaker, defibrillator, or loop recorder already implanted
- You have no recent heart surgery, heart attack, or stroke (within 3–6 months)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer type of ablation (pulsed field ablation) for people with persistent atrial fibrillation who have already had one ablation. The goal is to see if it can fix the heart rhythm problem again.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This trial tests a new type of ablation (pulsed-field) to treat persistent atrial fibrillation (AFib) that lasts more than 7 days. You may qualify if you have symptoms and haven't had other heart ablation procedures except for one specific type.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This trial tests whether using only ultrasound to guide a heart procedure called pulsed field ablation is as safe and effective as using X-ray. The procedure uses short energy pulses to fix irregular heartbeats in people with atrial fibrillation.
This study tests a new way to treat paroxysmal atrial fibrillation (AF) using pulsed field energy. The goal is to block abnormal electrical signals from the pulmonary veins and superior vena cava, which may help prevent AF episodes from coming back.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.